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IleocolonoscopyAbstract Background: Monitoring the disease activity in Crohn’s disease (CD) may be challeng-
ing with endoscopic manoeuvers due to difﬁculties in reaching the affected areas and being
restricted to mucosal lesions, so the existence of a more tolerable and reliable technique will be
highly warranted.
Objectives: This study aims at detection of CD’s activity by computed tomography enterography
(CTE) in correlation with ileocolonoscopy evaluation as well as detection of extra-enteric manifes-
tations and complications of the disease.
Materials and methods: Twenty-four patients who were clinically and histopathologically proven as
CD patients were retrospectively included in this study. Patients were divided into active and inac-
tive groups according to ileocolonoscopic evaluation. All patients underwent CTE as clinically indi-
cated within 1 week of ileocolonoscopy. Radiological parameters suggestive of Crohn’s disease
activity at CTE were interpreted at the terminal ileum and correlated to the corresponding ileocol-
onoscopy reports for signs of CD activity. Extra-enteric ﬁndings and complications of CD were also
reported if present.
Results: CTE was accurate in detecting CD activity in 15 out of 18 active cases (active group) and in
detecting disease inactivity in 5 out of 6 inactive cases (inactive group)with sensitivity and speciﬁcity of
83.3%. Mural hyperenhancement was the most distinguished sign of CD activity in CTE.
Conclusion: CTE is a non invasive and reliable technique that has a signiﬁcant value in assessment of
CD activity in correlation with endoscopy, hence, it is useful in follow up and preoperative guidance.
ª 2014 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. All rights
reserved.om (N.
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Endoscopic examination remains the gold standard in assess-
ment of disease activity in Crohn’s disease (CD). However,
the inﬂammatory process is commonly transmural and thus
mucosal appearance only can underestimate its true severity.1,2
Moreover, the extra-enteric complications of CD are hard
to detect with endoscopy, and as an invasive method, endos-
copy might be intolerable for CD patients who require
repeated examinations. Recently, capsule endoscopy has been
introduced as an efﬁcient tool and can provide clear images
of the small bowel. However, the risk of retention is as high
as 8% limiting its clinical applications.3
Former conventional radiological imaging techniques using
oral contrast as small bowel follow through and small bowel
enteroclysis were not accurate in diagnosing active CD in the
small bowel because the ﬁndings provided by both methods
are limited and indirect as regards the bowel wall and the
extra-luminal manifestations of CD. In addition, overlapping
of bowel loops may hinder the effectiveness of these methods.4
CT has become the modality of choice for detecting small
bowel diseases. CTE unlike abdominopelvic CT better displays
the small bowel wall as it depends on ingestion of large vol-
umes of enteric contrast material which distend the small
bowel lumen. The use of neutral enteric contrast agents like
water, combined with intravenous administration of contrast
material, allows excellent assessment of hypervascular lesions
and hyperenhancing bowel segments. In addition, CTE dis-
plays thin section images and is capable of delineating both
enteric and extra-enteric pathology unlike endoscopic or con-
ventional barium studies.5
As CD is a chronic disease characterized by remissions and
relapses, multiple examinations may be required to monitor
the disease status and the efﬁcacy of treatment. Therefore,
an easily performed technique that can be well tolerated by
patients and reliable for comparison of multiple examinations
needs to be established.
This study aims at detection of CD’s activity by computed
tomography enterography (CTE) in correlation with ileocolo-
noscopy evaluation as well as detection of extra-enteric mani-
festations and complications of the disease.
2. Materials and methods
2.1. Patients’ selection
This study was conducted from November 2012 to December
2013 in Ain Shams University Specialized Hospital, Cairo,
Egypt. We retrospectively studied 24 patients, who were clini-
cally and histopathologically proven as CD, with terminal
ileum involvement documented by ileocolonoscopy. Patients
were 15 males and 9 females, (mean age: 37.3 ± 11.5 years,
range 17–52 years). We included patients with CD who under-
went CTE preceded or followed by ileocolonoscopy within
1 week period during their hospital stay, ileocolonoscopy
reports were collected for the purpose of our study.
2.2. Ileocolonoscopy
Ileocolonoscopy was performed and reported by an experi-
enced gastroenterologist in terms of the Simple EndoscopicScore for Crohn’s Disease (SES-CD) which states that a score
between 0 and 2 suggests inactive disease and P3 suggests
active disease.62.3. CTE examinations
2.3.1. CTE protocol
All patients who underwent CTE were asked to take nothing
by mouth for 6 h before scanning. On the day of examination,
patients were asked to come 60 min before exam time, in which
patients were asked to ingest a total of 2000 mL of oral water
as a neutral contrast material mixed with mannitol (250 mL
hyperosmotic mannitol solution to 1750 mL water) over a
60-min period as follows: 0, 15, 30 and 40 min, the last inges-
tion is just before the scanning. Intramuscular buscopan 20 mg
is administered prior to scanning. Intravenous contrast mate-
rial (Omnipaque, 150 mg) was given at a rate of 4 mL/s then
patients were scanned using 12-Multislice CT (Deﬁnition
Flash, Siemens Medical Systems, Berlin, Germany) from the
porta hepatis to the symphysis pubis through single enteric
phase acquisition 30–40 s after IV contrast injection. Sec-
tion thickness used was 1.0 mm and the reconstruction interval
was 1 mm. The CT parameters are 280–320 mA, 120 kVp, a
pitch of 1.0. CT scans were then transferred to Syngo.via work
station for multiplanar reconstructions with section thickness
2 mm and interval 1 mm.2.3.2. CTE image interpretation
CTE images were interpreted by experienced consultants of
gastrointestinal tract radiology who were blinded to patients’
clinical and endoscopic evaluations. They were asked to eval-
uate the bowel especially the terminal ileum in each CTE exam
for; mural thickness and report its value in millimetres (mural
thickening is considered if the mural thickness >3 mm) and
CT signs of active CD which include; mural hyperattenuation
(hyperenhancement) which was detected visually and quantita-
tively by measuring the CT density at the wall of terminal
ileum in Hounseﬁeld Units (HU), mural hyperattenuation
was deﬁned as segmental hyperenhancement of the small
bowel wall which exceeds the enhancement of the adjacent
small bowel loop. Absolute ileal hyperenhancement >109
Hounseﬁeld Units (HU) correlates with active disease,7 mesen-
teric fat oedema deﬁned as increased density and stranding in
perienteric mesenteric fat compared to the perienteric fat adja-
cent to non-inﬂamed bowel loops, and comb’s sign which
refers to segmental dilatation of the vasa recta supplying a
bowel loop. Also CTE signs of inactive CD were interpreted
as mural thickening of the bowel wall or bowel stricture in
the absence of CTE signs of active disease. The extra-enteric
manifestations and complications of CD were also reported
with respect to the presence of abscesses, ﬁstula or stricture.2.4. Statistical analysis
Correlations between CT scan parameters of CD activity and
endoscopic scoring were carried out. Comparison of percent-
ages and mean values was done using Student’s t-test. Differ-
ences were considered highly statistically signiﬁcant at a
value of <0.001. Statistical analysis was done using SPSS
for Windows release 20 (SPSS Inc, Chicago, IL, USA).
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Our study included retrospectively 24 CD patients; they were
studied by CTE and ileocolonoscopy. Patients were divided
into two groups according to endoscopy reports of CD activ-
ity: active group (18 patients) with SES-CD score P3 and
inactive group (6 patients) with SES-CD score <3.
Ileocolonoscopy detected mucosal oedema and erosions as
the commonest ﬁndings in all 18 patients of the active group,
followed by active mucosal ulcers in 14 patients. While in the
inactive group, mucosal ulcer scars were the predominant
ﬁndings.Table 1 CTE enteric and extra-enteric ﬁndings reported in
CD patients of our study.
CTE ﬁndings No. of patients
(total = 24)
Percentage
(%)
Mural thickening (>3 mm) 21 87.5
Mural hyperenhancement (>109 HU) 15 62.5
Comb sign 11 45.8
Mesenteric fat oedema 14 58.3
Mesenteric lymph nodes 3 12.5
Abscess 6 25.0
Fistula 2 8.3
Stricture 4 16.0
Cholelithiasis 3 12.5
Sacroiliitis 2 8.3
Figure 1 Male patient, 40 years old with 18 year history of Crohn’s di
active Crohn’s disease in which there is multiple ileoileal ﬁstulae. The di
it forms a central pocket where the adjacent small bowel loops are su
Engorged vasa rectae ‘‘comb sign’’ is also noted (thin arrows). Ileocolo
edematous terminal ileum with an opening giving to a sinus tract.In our study CTE ﬁndings in CD patients are demonstrated
in Table 1. The most distinguished visual CT ﬁnding of active
CD was the mural hyperenhancement, followed by mural
thickening (Figs. 1–3). Mural thickenings and CTE signs of
CD activity were correlated to the reported ileocolonoscopic
results and are shown in Table 2.
Statistical analysis of CTE signs of activity in both active
and inactive groups of patients revealed a highly signiﬁcant
difference in the mural hyperenhancement sign (P< 0.001)
followed by comb sign (P< 0.05) between the two groups
(Table 2). No statistically signiﬁcant difference was found
between the two groups concerning the mesenteric fat oedema
sign. As regards the mucosal thickening sign, there was a
highly statistical signiﬁcant difference in terms of mean values
between the two groups denoting much higher thickening val-
ues of bowel wall in the active group, while no signiﬁcant dif-
ference was detected in terms of percentage values.
In correlation with ileocolonoscopic results, CTE correctly
diagnosed CD activity in 15 out of 18 patients of the active
group with 3 false negative cases. CTE correctly diagnosed 5
out of 6 cases with CD inactivity (Fig. 4) with one false posi-
tive case. Ileocolonoscopy as the reference standard revealed
mild active bowel inﬂammation in the 3 false negative cases
which was not detected by CTE while it revealed disease inac-
tivity in the false positive case by CTE, this was due to col-
lapsed bowel lumen giving the appearance of mural
thickening. Our study revealed equal sensitivity and speciﬁcity
(83.3%) of CTE in detecting CD activity and the positive pre-
dictive value (PPV) was 93.7% and negative predictive value
(NPV) was 62.5%.sease. CTE (sagital a & b, coronal c & d) shows imaging ﬁndings of
stal ileum shows mural thickening and hyperenhancement (arrow),
cked in and from which multiple ﬁstulae originate (arrow heads).
noscopic examination of this case revealed multiple deep ulcers in
Figure 2 Male patient 28 years old, with 2 year history of Crohn’s disease. CT enterography (axial a & b, coronal c) revealed active
Crohn’s disease with mural thickening and hyperenhancement involving the terminal ileum (arrow) and most of the large bowel
(arrowheads). The splenic ﬂexure is the seat of pericolic inﬂammatory process with stranding of the pericolic fat (asterisk) and multiple air
locules (thin arrow) are noted, consistent of a ‘‘phlegmon’’. Ileoconoscopy of this case revealed colonic and terminal ileum mucosal severe
oedema and acute ulcerations consistent with active CD.
Figure 3 Female patient 45 years old, with 7 month history of Crohn’s disease. Coronal CT enterography (a & b) revealed active form of
the disease with mural thickening, hyperenhancement (arrow) of the ileal loops and engorged vasa rectae ‘‘comb sign’’ (arrowheads)
denoting increased vascularity. Ileocolonoscopy of this case revealed oedema and active ulceration of the terminal ileum.
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CTE has been one of the primary diagnostic tools in the eval-
uation of patients with Crohn’s disease.8
In reference to ileocolonoscopy, CTE in our study correctly
diagnosed active cases of CD in 15 out of 18 patients of the
active group and 5 out of 6 cases of the inactive group with
PPV of 93.7% and NPV of 62.5%. The sensitivity and speciﬁc-
ity of CTE in diagnosing CD activity were 83.3%. There was a
highly statistically signiﬁcant difference with respect to mural
hyperenhancement as a sign of CD activity between the active
and inactive groups of patients (P< 0.001) while a statisticallysigniﬁcant difference (P< 0.05) was found between comb sign
as a second sign of CD activity and the mural thickening
between the two groups. No statistically signiﬁcant difference
was found between the two groups as regards the mesenteric
fat oedema sign.
Larger studies have also shown that ﬁndings of CD at CTE
correlate highly with endoscopy. For example, in a study car-
ried out by Hashimoto et al.9 in which they compared ﬁndings
from CTE with those from the mucosal surface in patients with
CD, they revealed a strong correlation between CTE ﬁndings
and mucosal surface ﬁndings. Siddiki et al.10 studied 33
patients with CD, they reported CTE sensitivity of 95.2% in
Figure 4 Female patient, 31 years old with 4 year history of Crohn’s disease. (a & b) CT enterography (axial a, coronal b) showing
circumferential mural thickening of the terminal ileum with no hyperenhancement (arrow) and narrowing of its lumen and dilatation of
the proximal ileal loops (arrowhead), mild ascites is also seen (asterisk). This was an inactive case of Crohn’s disease by CTE which
coincides with ileocolonoscopic ﬁndings of multiple mucosal ulcer scars.
Table 2 Mural thickening and CTE signs of CD activity in correlation with ileocolonoscopic results.
CTE signs of activity Ileocolonoscopy results P value
No. of active group
(18 patients)
No. of Inactive
group (6 patients)
Mural thickening (mean value in mm +/ standard
deviation and percentage)
11.6 ± 0.39
17 (94.4%)
6.35 ± 0.2
4 (66.7%)
<0.001
0.089
Mural hyperenhancement (mean value in HU +/ standard
deviation and percentage)
121 ± 28
15 (83.3%)
74 ± 15
0 (0%)
<0.001
<0.001
Comb sign 11 (61.1%) 0 (0%) 0.016
Mesenteric fat oedema 12 (66.7%) 2 (33.3%) 0.165
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who underwent CTE and ileoscopy, bowel wall thickening and
hyperenhancement on CTE correlated signiﬁcantly
(p< 0.001) with ileoscopic and histologic ﬁndings of active
CD.11 In a study comparing CTE, capsule endoscopy, small
bowel follow through, and ileocolonoscopy, researchers
reported sensitivity of 82% for CTE compared to 74% for
ileocolonoscopy and reported that CTE had speciﬁcity of
89% compared to 100% for ileoconoscopy.12 Hara and his
colleagues13 observed that CTE ﬁndings positively correlated
with CD disease progression or regression.
We found mural hyperenhancement sign to be the most
visually distinguishable CT ﬁnding of CD disease activity fol-
lowed by terminal ileal thickening.14 Terminal ileal mural
hyperenhancement was highly signiﬁcant in patients with
active CD than in patients with inactive CD (p< 0.001) in
respect to both percentages and mean value correlation denot-
ing the signiﬁcant incidence and quantitative value of mural
hyperenhancement in the active CD patients. This quantitative
ﬁnding correlated with visual estimates of disease activity by
the reporting radiologists.
Terminal ileal thickening was the second signiﬁcant CTE
sign after mural hyperenhancement between patients of the
active and inactive groups. There was a highly statistical signif-
icant difference in terms of mean values only between the two
groups (p< 0.001) denoting much higher thickening values of
bowel wall in the active group, while no signiﬁcant difference
was detected in terms of percentage values revealing the exist-
ing incidence of mural thickening in inactive CD.
The commonest extra-enteric complications reported in our
study included peri-enteric abscesses and phlegmons (Fig. 2)
followed by strictures and ﬁstula (Fig. 1).Booya et al.15 demonstrated that CT enterography cor-
rectly identiﬁes the presence or absence of ﬁstulae in 94% of
patients and early adhesions, resulting in changes in the treat-
ment regimen in 61% of patients.
In correlation with ileocolonoscopy, CTE in our study pro-
vided a signiﬁcant correlation in both the active and inactive
groups. CT criteria for active disease especially mucosal hype-
renhancement and comb sign were good predictors of active
CD. In addition, CTE ﬁndings aided to assess extra-enteric
manifestations of CD and its complications.
5. Conclusions
In conclusion, CTE is a non invasive and reliable technique
that has a signiﬁcant value in assessment of CD activity in cor-
relation with endoscopy, hence, it is useful in follow up and
preoperative guidance.Conﬂicts of interest
None declared.References
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